|
To learn more about AbbVie, click here.
• AVEO ACE
• Kyowa Kirin Cares
• Takeda Oncology's Here 2 Assist Details >
• Medicare Part A Place of Service
• Complex Non-Chemotherapeutic Drug Administration
• Expedited Prior Authorization Requests
• Medicare Hot Links
• And More Details >New training opportunities availableDetails >
Recent Oncology Related Articles• Part B - Hospital Outpatient Average Sales Price (ASP)
• MLN Matters Details >This edition includes articles on• Developing! Appeal Process for Certain Changes in Status for Medicare
• Why is the Hottest Topic Not Included in the No Surprises Act?
• Shaping the Future: AI and Innovation in Coding
• Important: Cancer Numbers on the Rise for Young Women Details >
Recent Oncology Related News• Additional Fee Schedules Added to Provider Portal
• Additional Fee Change Schedules Added to Provider Portal
• Piasky and Tremfya to Have a Site-of-Care Requirement
• Step Therapy Requirement Added for Darzalex Faspro
• And More Details >Publications• The Record
• BCN Provider News Details >
Last Reviewed/Updated 2-18-25• Update! Procrit or Epoetin Class Drugs Maintenance
• BCBSM Below Cost Reimbursement Details >Last Reviewed/Updated 2-18-25• 0885 Claims Denied With Reason Code 693
• Procrit or Epoetin Class Drugs Maintenance
• Procrit Denials (693)
• 505(b)(2) Oncology Products Being Impacted by Prior Auth Details >• February 2025 OfficeLink Update
• Correction: Reimbursement for Modifiers SA & SB Details >• Payment of Observation Hospital Stays
• Update - Medical Record Review Projects
• Ordering Genetic Tests for HAP Members
• Multifactor Authentication (MFA) Coming Soon
• New HAP 2025 Medicare Advantage Plans Details >• MMP Bulletins
• Biller "B" Aware Notice Details >• We're Closing Fax Number
• NCQA's 2025 HEDIS Audit is Underway
• Medicaid Formulary Changes Effective Feb. 1, 2025
• Updated TurningPoint Provider Training Guide Available
• CPAP & BiPAP Rental Guidelines Reminder Details >• Medical Policy Updates
• Reimbursement Policy Updates
• Pharmacy and Clinical Updates
• GEHA Members Have New ID Cards Details >
• AstraZenca & Daiichi Sanyko Enhertu (trastuzumab deruxtecan)
• SpringWorks Therapeutics Gomekli™ (mirdametinib)
• Pfizer Adcetris® (brentuximab vedotin)
• Deciphera Romvimza™ (vimseltinib) Details > 
February 2025 Frequently Asked Questions• 96523 for a Routine Port Flush?
• Can an IVP be Coded Without a Recorded Stop Time
• Coding for IV Infusions That Begin Outside the Observation Unit
• Coding Phone Calls on a Medicare Beneficiary Details > |
